Clyde Biosciences Cardiomyocyte Assay
Home
Contact
Cardiac Safety Cardiac Drug Discovery
CellOPTIQ® Platform Evidence Assay Comparison
Services Overview Primary Screening Assay CiPA Assay Mechanistic CV Toxicity Heart Failure Assay hiPSC CMC Characterisation Voltage Assay Calcium Assay Contractility Assay In Silico Modelling Custom R&D
Working with Clyde Team News
Home Applications Cardiac Safety Cardiac Drug Discovery Technical CellOPTIQ® Platform Evidence Assay Comparison Services Services Overview Primary Screening Assay CiPA Assay Mechanistic CV Toxicity Heart Failure Assay hiPSC CMC Characterisation Voltage Assay Calcium Assay Contractility Assay In Silico Modelling Custom R&D About Working with Clyde Team News
Clyde Biosciences Cardiomyocyte Assay
CellOPTIQ the leading cardiomyocyte assay
Contact

New Website

 

WELCOME TO OUR NEW WEBSITE

Clyde Biosciences is delighted to launch our new website. Have a good look around and please get in touch with feedback or inquiries.

 
Ian Whalley14 February 2017
Facebook0 Twitter LinkedIn0 0 Likes
Previous

Groundbreaking Research Into Kinases Using CellOPTIQ From Clyde Biosciences

Ian Whalley28 June 2017
Next

Clyde Biosciences Autumn Business Update

Ian Whalley30 November 2016

Find out more: info@clydebio.com +44 (0)1698 539920

Clyde Biosciences Limited
Bo'Ness Road,
Newhouse, Lanarkshire, Scotland, ML1 5UH,
United Kingdom
+44 (0)1698 539920 info@clydebio.com
Hours
Applications
Cardiac Safety Cardiac Drug Discovery
Technical
CellOPTIQ® Platform Evidence Assay Comparison
Services
CiPA Assay Mechanistic CV Tox Assay Heart Failure Assay hiPSC CMC Characterisation Voltage Assay Calcium Assay Contractility Assay In Silico Modelling Custom R&D
About Clyde
Working With Us Team News Contact Us

Site Map • Privacy and Cookie Policy
Clyde Biosciences © 2017-21 | Company registration No. SC418838. Registered office: BioCity Scotland, Bo'ness Road, Motherwell ML1 5UH